Organic compounds -- part of the class 532-570 series – Organic compounds – Unsubstituted hydrocarbyl chain between the ring and the -c-...
Patent
1992-04-03
1995-08-29
Geist, Gary
Organic compounds -- part of the class 532-570 series
Organic compounds
Unsubstituted hydrocarbyl chain between the ring and the -c-...
546124, 546224, 548567, C07D22316, C07D45102, C07D21156, C07D20708
Patent
active
054461472
ABSTRACT:
This invention relates to novel dopamine D-1 and D-2 imaginging agents which are both fluorinated and iodinated and can appropriately labelled for use in both PET and SPECT imaging. Compounds include S-(-)-2-fluoroethoxy-3-methyl-N-[(1-ethyl-2-pyrrolidinyl)methyl]-5-iodoben zamide and R(+)-2,3-dimethoxy-N-[(1-(4'-fluorobenzyl)-2-pyrrolidinyl)methyl]-5-iodobe nzamide.
REFERENCES:
patent: 5068326 (1991-11-01), Kung
Chumpradit, S., et al., "Synthesis and Resolution of (.+-.)-7-Chloro-8-hydroxy-1-(3'-iodophenyl)-3-methyl-2,3,4,5-tetrahydro-1H -3-benzazepine (TISCH): A High Affinity and Selective Iodinated Ligand for CNS D1 Dopamine Receptor", J. Med. Chem. 34, No. 3: 877-883 (1991).
Billings, J. J., et al., "Characterization of Radioiodinated TISCH: A High-Affinity and Selective Ligand for Mapping CNS D.sub.1 Dopamine Receptor", J. Neurochem 58, No. 1: 227-236 (1992).
Hogberg, T., et al., "New selective dopamine D-2 antagonists as antypsychotic agents Pharmacological, chemical, structural and theoretical considerations", Acta Pharm. Suec. 24: 289-328 (1987).
Halldin, C., et al., "A Comparative PET-Study of Five Carbon-11 or Fluorine-18 Labelled Salicylamides. Preparation and In Vitro Dopamine D-2 Receptor Binding", Nucl. Med. Biol. 18, No. 8: 871-881 (1991).
Hogberg, T., et al., "Potential Antipsychotic Agents. 9. Synthesis and Stereoselective Dopamine D-2 Receptor Blockade of a Potent Class of Substituted (R)-N-[(1-Benzyl-2-pyrrolidinyl)methyl]benzamides. Relations to Other Side Chain Congeners", J. Med. Chem. 34: 948-955 (1991).
de Paulis, T., et al., "22. Quantitatie Structure-Affinity Relationships of Dopamine D.sub.2 Receptor Antagonists: A Comparison between Orthopramides and 6-Methoxysalicylamides", Helvetica Chimica Acta 74: 241-254 (1991).
Yue, E. W., et al., "Synthesis of 2,3-Dimethoxy-5-iodobenzoic Acid", J. Org. Chem. 56: 5451-5456 (1991).
Kessler, R. M., et al., "High Affinity Dopamine D2 Receptor Radioligands. 1. Regional Rat Brain Distribtuion of Iodinated Benzamides", J. Nucl. Med. 32 No. 8: 1593-1600 (1991).
Murphy, R. A., et al., "Synthesis and Characterization of Iodobenzamide Analogues: Potential D-2 Dopamine Receptor Imaging Agents", J. Med. Chem. 33, No. 1:171-178 (1990).
Kung, H. F., et al., "Current and Future Radiopharmaceuticals for Brain Imaging With Single Photon Emission Computed Tomography", Seminars in Nuclear Medicine, vol. XX, No. 4: 290-302 (1990).
Kung, H. F., et al., "In Vitro and In Vivo Evaluation of [.sup.123 I]IBZM: A Potential CNS D-2 Dopamine Receptor Imaging Agent", J. Nucl. Med. 30, No. 1: 88-92 (1989).
Kung, H. F., et al., "In Vivo SPECT Imaging of CNS D-2 Dopamine Receptors: Initial Studies with Iodine-123-IBZM in Humans", J. Nucl. Med. 31: 573-579 (1990).
Kung, M-P., et al., "The Characterization of IBF as a New Selective Dopamine D-2 Receptor Imaging Agent", J. Nucl Med. 31: 648-654 (1990).
Kung, M-P., et al., "A Kit Formulation for Preparation of Iodine-123-IBZM: A New CNS D-2 Dopamine Receptor Imaging Agent", J. Nucl. Med. 32: 339-342 (1991).
Hoegberg et al., "Synthesis & Binding Properties of the New Fluorinated Benzamide NCQ616", Acta Pharm. Nord. 4(4), pp. 297-300, 1992. (abstract provided in action).
Chumpradit Sumalee
Kung Hank F.
Kung Mei Ping
Chapman Lara E.
Geist Gary
Trustees of the University of Pennsylvania
LandOfFree
Fluorinated and iodinated dopamine agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fluorinated and iodinated dopamine agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fluorinated and iodinated dopamine agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1820237